SEK 98.05
(1.24%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 13.31 Billion SEK | 5.36% |
2022 | 12.63 Billion SEK | 10.08% |
2021 | 11.47 Billion SEK | 3.56% |
2020 | 11.08 Billion SEK | 0.39% |
2019 | 11.04 Billion SEK | 81.7% |
2018 | 6.07 Billion SEK | 4.47% |
2017 | 5.81 Billion SEK | 2.21% |
2016 | 5.69 Billion SEK | 30.89% |
2015 | 4.34 Billion SEK | 4.42% |
2014 | 4.16 Billion SEK | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 3.48 Billion SEK | 2.11% |
2024 Q2 | 3.51 Billion SEK | 1.0% |
2023 Q4 | 3.41 Billion SEK | 1.7% |
2023 Q3 | 3.35 Billion SEK | 1.36% |
2023 Q1 | 3.23 Billion SEK | 0.31% |
2023 Q2 | 3.31 Billion SEK | 2.32% |
2023 FY | 13.31 Billion SEK | 5.36% |
2022 Q2 | 3.14 Billion SEK | 2.05% |
2022 FY | 12.63 Billion SEK | 10.08% |
2022 Q4 | 3.22 Billion SEK | 1.19% |
2022 Q3 | 3.18 Billion SEK | 1.4% |
2022 Q1 | 3.08 Billion SEK | 3.08% |
2021 FY | 11.47 Billion SEK | 3.56% |
2021 Q1 | 2.72 Billion SEK | -1.34% |
2021 Q2 | 2.85 Billion SEK | 4.55% |
2021 Q3 | 2.91 Billion SEK | 2.14% |
2021 Q4 | 2.98 Billion SEK | 2.61% |
2020 Q1 | 2.81 Billion SEK | 0.29% |
2020 Q2 | 2.77 Billion SEK | -1.25% |
2020 Q4 | 2.76 Billion SEK | 1.17% |
2020 Q3 | 2.73 Billion SEK | -1.59% |
2020 FY | 11.08 Billion SEK | 0.39% |
2019 FY | 11.04 Billion SEK | 81.7% |
2019 Q4 | 2.8 Billion SEK | -1.41% |
2019 Q3 | 2.84 Billion SEK | -1.18% |
2019 Q2 | 2.87 Billion SEK | 14.35% |
2019 Q1 | 2.51 Billion SEK | 62.32% |
2018 FY | 6.07 Billion SEK | 4.47% |
2018 Q4 | 1.55 Billion SEK | 0.58% |
2018 Q3 | 1.54 Billion SEK | 1.52% |
2018 Q2 | 1.51 Billion SEK | 3.48% |
2018 Q1 | 1.46 Billion SEK | 0.2% |
2017 Q3 | 1.48 Billion SEK | 3.19% |
2017 FY | 5.81 Billion SEK | 2.21% |
2017 Q4 | 1.46 Billion SEK | -1.61% |
2017 Q1 | 1.42 Billion SEK | -19.48% |
2017 Q2 | 1.44 Billion SEK | 1.41% |
2016 Q1 | 1.19 Billion SEK | 0.0% |
2016 FY | 5.69 Billion SEK | 30.89% |
2016 Q4 | 1.76 Billion SEK | 28.34% |
2016 Q3 | 1.37 Billion SEK | 1.78% |
2016 Q2 | 1.35 Billion SEK | 12.95% |
2015 FY | 4.34 Billion SEK | 4.42% |
2014 FY | 4.16 Billion SEK | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Attendo AB (publ) | 17.28 Billion SEK | 22.994% |
Humana AB (publ) | 9.64 Billion SEK | -37.962% |
ProstaLund AB (publ) | 22.2 Million SEK | -59847.762% |